AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 291: H2098-H2106, 2006. First published June 2, 2006; doi:10.1152/ajpheart.00396.2006
0363-6135/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/5/H2098    most recent
00396.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dumka, D.
Right arrow Articles by Borejdo, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dumka, D.
Right arrow Articles by Borejdo, J.

E22K mutation of RLC that causes familial hypertrophic cardiomyopathy in heterozygous mouse myocardium: effect on cross-bridge kinetics

D. Dumka,1 J. Talent,1 I. Akopova,1 G. Guzman,2 D. Szczesna-Cordary,2 and J. Borejdo1

1University of North Texas Health Science Center, Fort Worth, Texas; and 2University of Miami Miller School of Medicine, Miami, Florida

Submitted 17 April 2006 ; accepted in final form 27 May 2006

Familial hypertrophic cardiomyopathy is a disease characterized by left ventricular and/or septal hypertrophy and myofibrillar disarray. It is caused by mutations in sarcomeric proteins, including the ventricular isoform of myosin regulatory light chain (RLC). The E22K mutation is located in the RLC Ca2+-binding site. We have studied transgenic (Tg) mouse cardiac myofibrils during single-turnover contraction to examine the influence of E22K mutation on 1) dissociation time ({tau}1) of myosin heads from thin filaments, 2) rebinding time ({tau}2) of the cross bridges to actin, and 3) dissociation time ({tau}3) of ADP from the active site of myosin. {tau}1 was determined from the increase in the rate of rotation of actin monomer to which a cross bridge was bound. {tau}2 was determined from the rate of anisotropy change of the recombinant essential light chain of myosin labeled with rhodamine exchanged for native light chain (LC1) in the cardiac myofibrils. {tau}3 was determined from anisotropy of muscle preloaded with a stoichiometric amount of fluorescent ADP. Cross bridges were induced to undergo a single detachment-attachment cycle by a precise delivery of stoichiometric ATP from a caged precursor. The times were measured in Tg-mutated (Tg-m) heart myofibrils overexpressing the E22K mutation of human cardiac RLC. Tg wild-type (Tg-wt) and non-Tg muscles acted as controls. {tau}1 was statistically greater in Tg-m than in controls. {tau}2 was shorter in Tg-m than in non-Tg, but the same as in Tg-wt. {tau}3 was the same in Tg-m and controls. To determine whether the difference in {tau}1 was due to intrinsic difference in myosin, we estimated binding of Tg-m and Tg-wt myosin to fluorescently labeled actin by measuring fluorescent lifetime and time-resolved anisotropy. No difference in binding was observed. These results suggest that the E22K mutation has no effect on mechanical properties of cross bridges. The slight increase in {tau}1 was probably caused by myofibrillar disarray. The decrease in {tau}2 of Tg hearts was probably caused by replacement of the mouse RLC for the human isoform in the Tg mice.

confocal microscopy; anisotropy



Address for reprint requests and other correspondence: J. Borejdo, Univ. of North Texas Health Science Center, Fort Worth, TX 76107 (e-mail: jborejdo{at}hsc.unt.edu)




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
S. Morimoto
Sarcomeric proteins and inherited cardiomyopathies
Cardiovasc Res, March 1, 2008; 77(4): 659 - 666.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
D. Szczesna-Cordary, M. Jones, J. R. Moore, J. Watt, W. G. L. Kerrick, Y. Xu, Y. Wang, C. Wagg, and G. D. Lopaschuk
Myosin regulatory light chain E22K mutation results in decreased cardiac intracellular calcium and force transients
FASEB J, December 1, 2007; 21(14): 3974 - 3985.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
O. M. Hernandez, M. Jones, G. Guzman, and D. Szczesna-Cordary
Myosin essential light chain in health and disease
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1643 - H1654.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.